|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/2013 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3300483 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16818153.5 |
| Europos patento paraiškos padavimo data | 2016-06-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-11-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2016/006513 |
| Data | 2016-06-20 |
| (87) | Numeris | WO 2017/003120 |
| Data | 2017-01-05 |
| (30) | Numeris | Data | Šalis |
| 20150093413 | 2015-06-30 | KR |
| (72) |
PARK, Caleb Hyung Min , KR
JUNG, Myeong Ki , KR
KIM, Jin Cheul , KR
KIM, Yong Il , KR
PARK, Jae Hyun , KR
WOO, Jong Soo , KR
|
| (73) |
Hanmi Pharm. Co., Ltd. ,
214 Muha-ro
Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536,
KR
|
| (54) | ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME |
| ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME |